In recent years, growing interest has been manifested for the potential of substances psychedelic in the treatment of mental health problems, including the post-traumatic stress syndrome (SSPT) and depression. A new analysis has revealed promising results in mental health and cognition of special forces of special forces following a combination of psychedelic treatments. This article will explore the results of this analysis, highlighting the potential advantages of psychedelic therapy for the mental health of veterans.
# Study and treatment
The analysis focused on a group of special forces of the United States special forces who followed a treatment in a clinic in Mexico. The treatment included a combination of ibogaine hydrochloride, derived from the Iboga plant from West Africa, and 5-meo-dmt, a psychedelic substance secreted by the toad of Colorado River. The researchers noted that each of these psychedelic treatments reduced depression and anxiety while improving cognitive capacities in the veterans participating.
The analysis was carried out by researchers from Ohio State University, where therapy assisted by the psilocybin is currently studied in Ohio State for the treatment of the SSPT among veterans, and has been published in the American Journal of Drug and Alcohol Abuse .
## Mental health challenges for veterans
Many special forces veterans often do not respond to traditional therapies for complex psychiatric symptoms. This underlines the need for innovative approaches in the treatment of mental health. Veterans who participated in the clinical retirement program were mainly soldiers in active service after September 11, seeking care for problems such as memory problems, head trauma, depression, anxiety, sspt , problems of sleep, anger and fatigue.
## Previous assessment to treatment
Before treatment, researchers carried out prior questionnaires to assess various mental health symptoms, life satisfaction, anger levels and suicidal trends. The analysis included 86 veterans, each receiving a single dose of oral chlorhydrate ibogaine and at least three additional doses of inhalation totaling 50 milligrams of 5-meo-dmt another day. Preparation and integration sessions were carried out before and after each treatment.
## Unexpected discoveries and cognitive capacities
Alan Davis, the main author of the study, underlined the unique challenges that this group of veterans is faced, often exposed to repeated traumatic events in the context of their work. The accumulation of these difficulties, including cranial trauma, predisposes individuals to mental health problems. Davis has found particularly striking that treatment leads to improvements in cognitive capacities linked to brain trauma, which is an unexpected discovery. This suggests that psychedelics can have a wide range of potential advantages in different fields.
## Results of the analysis
Analysis has revealed significant improvements in self-declared TSPT symptoms, depression, anxiety, severity of insomnia and anger, as well as a significant increase in life satisfaction between pre-treatment and followed by one month. The profits have maintained at three and six months' follow-up, with continuous improvements in the reduction of disability and post-combination symptoms, as well as a substantial increase in psychological flexibility and cognitive capacities.
## Exploration of improvement mechanisms
Improving cognitive capacities requires additional research to determine whether it results from a decrease in symptoms of mental health, changes in brain signaling or a combination of the two. Researchers have also noted that changes in psychological flexibility, the ability to act in accordance with its values despite internal or external experiences, have been linked to revealing and mystical psychedelic experiences in previous research.
## Experiences and attitudes of participants
The majority of participants reported moderate to important desirable changes in their attitudes, behaviors and relationships. One month after treatment, 48.6% said that psychedelic experience was the most significant on the spiritual level of their lives, while 42.9% described it as psychologically enlightening And 17.1% considered him the most stimulating or difficult experience of their lives.
## Conclusion
The results of this analysis demonstrate the potential of psychedelic therapy in improving mental health results in veterans with a history of complex trauma. The researchers highlight the importance of continuing to test the therapies assisted by psychedelics in clinical trials in the United States, in particular for the populations of veterans who have not responded to traditional treatments. Additional research is necessary to better understand the mechanisms underlying these improvements and guaranteeing the safe and effective use of psychedelics in the treatment of mental health.
Coaching learn more
Download the Sweet Spot app
## FAQ
1. Can psychedelic therapy help veterans with TSPT and depression?
Yes, the analysis revealed that the combination of psychedelic treatments led to improvements in mental health results, including a reduction in TSPT and depression symptoms.
2. Are improvements in cognitive capacities lasting?
The profits have maintained at three and six months' follow -ups, which suggests that improvements in cognitive capacities are durable.
3. Are there side effects associated with psychedelic therapy?
Although psychedelic therapy has shown promising results, it is important to note that individual experiences can vary and side effects may occur. These effects must be monitored and managed carefully by qualified professionals.
4. Is psychedelic therapy legal to treat mental health disorders?
The legal status of psychedelic therapy varies according to countries and regions. It is essential to consult local regulations and seek treatment with approved professionals.
5. How can veterans access psychedelic therapy?
Veterans interested in psychedelic therapy must consult their health care providers and explore clinical trials or programs that offer these treatments.
6. Are there risks associated with psychedelic therapy for veterans?
As with any medical treatment, potential risks are associated with psychedelic therapy. These risks must be carefully evaluated and discussed with healthcare professionals before undergoing treatment.
7. Can psychedelic therapy be combined with other processing approaches?
Psychedelic therapy can be used in addition to other traditional approaches, such as psychotherapy and drugs. It is essential to work with health professionals to develop an integrated treatment plan.
8. Are research studies on psychedelic therapy for veterans in progress?
Yes, research studies are underway to explore the use of psychedelic therapy in veterans with mental health problems. These studies aim to better understand the potential advantages and to optimize treatment protocols.
9. How can veterans face mental health challenges while waiting to access psychedelic therapy?
Veterans can explore other proven treatments, such as cognitive behavioral therapy and mindfulness practices, to manage their mental health while waiting to access psychedelic therapy.
10. Are there any support networks or organizations specifically dedicated to veterans looking for alternative treatments for mental health?
Yes, there are organizations and support networks specifically dedicated to helping veterans explore alternative treatments for mental health. These resources can provide advice, information and peer support.
